Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Advanced Therapies
Filter
Filter
Sort By
Newest First
Sector
Modality / Product
Service / Activity
Reset
1 / 27
1 / 27
AAV
Overcoming Variability and Scaling Challenges in AAV Manufacturing
Rafal Garus
Viralgen Vector Core
PAO-08-24-CL-03
July 22, 2024
Cell and Gene Therapy
Managing Complex Sample and IP Logistics in Support of Cell and Gene Therapies
Erin Schaller; Aidan Jones
PPD
PAO-06-24-CL-11
July 09, 2024
Cell Therapy
Genezen to Acquire uniQure's Commercial Gene Therapy Manufacturing Operations in Lexington, MA
Genezen
PR-07-24-NI-01
July 02, 2024
Cell Therapy
Facilitating Organoid Production for Biopharmaceutical Applications
Karen Weisinger, Ph.D.
Cell X Technologies
PAO-06-24-CL-12
July 02, 2024
Synthetic DNA
Transforming the Economics of AAV Manufacture While Optimizing Quality with dbDNA
Tom Merritt, Ph.D.
Touchlight
PAO-07-24-CL-01
July 02, 2024
Protein Degradation
PROTACS: Upgrading Small Molecule Inhibitors
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-06-24-NI-02
June 11, 2024
Cell Therapy
Intelligent Cell Processing Enables Consistent, Reproducible, and Scalable GMP-Compliant Processes
Karen Weisinger, Ph.D.
Cell X Technologies
PAO-06-24-CL-07
May 30, 2024
Lipid Nanoparticles
Feasibility Studies and cGMP Design Supporting Continuous Lipid Nanoparticle Manufacturing
Jim Ziogas
DIANT Pharma
PAO-05-24-CL-03
May 30, 2024
Exosomes
Bright Outlook for Exosome-Based Therapeutics and Diagnostics Despite Numerous Hurdles
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-05-24-NI-01
May 09, 2024
mRNA Innovations
Technology Advances Needed to Drive Future mRNA Growth
Hagen Richter, Ph.D.
PAO-04-24-CL-04
April 15, 2024
Cell and Gene Therapy Regulatory
Navigating Regulatory Complexity for Cell and Gene Therapies
Natasha Rivas
PAO-04-24-CL-03
April 12, 2024
mRNA Manufacturing
Navigating mRNA Manufacturing with Flexibility and Innovation
Michael van der Horst, Ph.D.
PAO-04-24-CL-02
April 08, 2024
Nice Insight Reports
Biotech Funding Ups and Downs
April Stanley, MS MBA
PAO-04-24-NI-01
April 02, 2024
pDNA Manufacturing
Overcoming pDNA Supply Challenges for mRNA Manufacturing
Mack Kuo, Ph.D.
PAO-04-24-CL-01
April 01, 2024
mRNA–LNP Manufacturing
The Innovators Bringing Continuous Manufacturing to Lipid Nanoparticles
Antonio Costa, Ph.D.; William Pasek
DIANT Pharma
PAO-03-24-CL-08
March 18, 2024
Radioconjugate development
Expediting Radioimmune Conjugate Pharmaceuticals for First-In-Human Phase 0 Proof-of-Concept Human Studies from Stable Pool
Muctarr Sesay, Ph.D.; Natalia Bourguignon, Ph.D.
GBI
PAO-03-24-CL-07
March 15, 2024
Viral Vectors
A Viral Vector CDMO Vision that Resonates
Drew Brennan; Chris Berger; Elie Hanania, Ph.D.; Dave Ingamells; Rami Barghout, PE
Avid Bioservices
PAO-03-24-CL-06
March 14, 2024
Manufacturing Partnership
Genezen Announces Strategic Process Development and Manufacturing Partnership Agreement with Seattle Children’s Research Institute for X-linked Agammaglobulinemia (XLA) Cell Therapy Program
Genezen
PR-M03-24-01-5831
March 06, 2024
Lentivirus Production
Genezen Enters Licensing Agreement with CSL for the Cytegrity™ Stable Lentivirus Production System
Genezen
PR-M02-05-02
February 21, 2024
Cell Therapy Manufacturing
Rethinking Cell Engineering for Cell Therapy Manufacturing
Todd Sulchek, Ph.D
CellFE
PAO-11-23-CL-03
December 13, 2023